Global Mycophenolate Mofetil Market Outlook 2017-2022
- Table Of Content
- Licence Rights
- Section Purchase
Mycophenolate mofetil is a prodrug of mycophenolic acid (MPA), an inhibitor of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil is marketed under the trade name CellCept and mycophenolate sodium as Myfortic.
The five-year forecast for the mycophenolate mofetil market shows a healthy Compound Annual Growth Rate (CAGR) of 5.3 percent driven by increased demand, according to a new report published by Gen Consulting Company.
The report covers forecast and analysis for the mycophenolate mofetil market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both output/volume and revenue. The study then describes the drivers and restraints for the mycophenolate mofetil market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the mycophenolate mofetil market on a global level.
The report has been prepared based on the synthesis, analysis, and interpretation of information about the global mycophenolate mofetil market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.
On the basis of products, the market for mycophenolate mofetil is segmented into Capsule, Tablet, Injection, others. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in global mycophenolate mofetil market.
Key Product Types
Middle East and Africa
RPG Life Sciences
request free sample to get a complete list of companies
Key Questions Answered in this Report
What will the market size be in 2022?
What are the key factors driving the global mycophenolate mofetil market?
What are the challenges to market growth?
Who are the key players in the mycophenolate mofetil market?
What are the market opportunities and threats faced by the key players?
Table Of Content
Part 1. Exclusive Summary
Part 2. Methodology
2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered
Part 3. Introduction
3.1 Product Overview
3.2 Mechanisms of Action
3.3 Manufacturing Process
3.3.1 Raw Materials
3.3.2 Cost Analysis
Part 4. Competitive Landscape
4.1 Global Mycophenolate Mofetil Market, by Volume 2012-2017
4.1.2 Global Mycophenolate Mofetil Market, by Volume, by Company
4.1.3 Top 10 Companies by Volume Share
4.2 Global Mycophenolate Mofetil Market, by Revenue 2012-2017
4.2.2 Global Mycophenolate Mofetil Market, by Revenue, by Company
4.2.3 Top 10 Companies by Revenue Share
Part 5. Market Dynamics
5.1 Market Drivers
Part 6. Segmentation by Application
Part 7. API Supply by Region
7.1 Global Mycophenolate Mofetil Volume by Region
7.1.1 North America
7.2 Global Mycophenolate Mofetil Revenue by Region
7.2.1 North America
Part 8. Consumption Pattern
8.1 North America
8.1.2 by Application
8.1.3 by Country (U.S., Canada, Mexico, etc.)
8.2.2 by Application
8.2.3 by Country (Germany, UK, France, Spain, Italy, etc.)
8.3.2 by Application
8.3.3 by Country (China, Japan, Korea, India, etc.)
8.4.2 by Application
8.4.3 by Country (Saudi Arabia, Turkey, Nigeria, Iran, South Africa, etc.)
8.5 South America
8.5.2 by Application
8.5.3 by Country (Brazil, Argentina, Colombia, etc.)
Part 9. Mycophenolate Mofetil Market Forecast
9.1 Global Mycophenolate Mofetil Market Size 2017-2022
9.2 Global Mycophenolate Mofetil Market by Region 2017-2022
9.2.1 North America
9.3 Global Mycophenolate Mofetil Consumption 2017-2022
9.4 Global Mycophenolate Mofetil Market by Application 2017-2022
Part 10. Company Profiles
10.1.1 Business Overview
10.1.2 Products Offered
10.6 Concord Biotech
10.7 Excella Gmbh
10.9 Huadong Medicine
10.10 Hubei Teyer
10.11 Hunan Warrant
10.15 PKU Healthcare
10.16 Roche Pharma
10.17 RPG Life Sciences
Part 11. Industry Activity
11.1 M&As, JVs and Partnership
11.2 Other Developments
Part 12. Appendix
allows one individual to access the purchased report
allows five individuals to access the purchased report
allows all employees of an organization to access the purchased report